Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for ILMN, sign up here.
Income Statement
Revenue
$4.5bn
Gross Profit
$2.7bn
Earning before Tax
$-1.1bn
Net Income
$-1.2bn
Net Income Common Shareholders
$-1.2bn
EPS
-7.34
Balance Sheet
Cash
$1.0bn
Debt
$2.2bn
Assets
$10.1bn
Liabilities
$4.4bn
Equity
$5.7bn
Enterprise Value
$23.4bn
Cash Flow Statement
Net Cash from Operations
$478.0m
Net Cash from Investing
$-0.2bn
Net Cash from Financing
$-1.2bn
Net Cash Flow
$-1.0bn
Free Cash Flow
$283.0m
Free Cash Flow per Share
$1.79
Metrics
Price to Equity
-0.0m
Price to Equity (Damodaran)
-18.97
Price to Book
3.85
Net Margin
-0.26
Return on Equity
-0.19
Return on Sales
-0.23
Get immediate access to 5-years of reference grade data for ILMN for free.
Sign upIllumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Company Info
Industry
Diagnostics & Research
Employees
11,500
Address
5200 Illumina Way
San Diego, CA 92122
United States
Phone
858 202 4500
Website
Last Updated
2024-02-08
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.